CRBU CIK: 1619856

Caribou Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.5
FY22:
−91.0
FY23:
−93.3
FY24:
−138
FY25:
−111
Change from FY21 to FY25
millions USD
FY21:
−176
FY22:
−93.2
FY23:
−68.2
FY24:
86.6
FY25:
102
Change from FY21 to FY25
millions USD
FY21:
433
FY22:
2.13
FY23:
154
FY24:
16.7
FY25:
4.82
millions USD
FY21:
225
FY22:
−182
FY23:
−7.18
FY24:
−34.9
FY25:
−3.93
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.6
FY22:
−97.4
FY23:
−105
FY24:
−143
FY25:
−112

All amounts in millions USD Data source:SEC EDGAR